Last updated 2026-07-20
- Acquired by BioTime Inc., May 2010
- Raised $7.1M Undisclosed Round led by BioTime Inc., Sep 2010
- Raised $2.5M grant, Apr 2019
Total raised
$21.8M
Last: Grant 2019-05
Stage
Seed
Founded
2005
Headcount
43
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Cell Cure Neurosciences is a biotechnology company based in Jerusalem, Israel, founded in 2005. It focuses on developing cell therapies for retinal and neurodegenerative diseases using human embryonic stem cells (hESC). The company's proprietary platform generates retinal epithelial cells, with its lead product, OpRegen™, targeting age-related macular degeneration (AMD). Cell Cure is a subsidiary of Lineage Cell Therapeutics (formerly BioTime Inc.) and has partnered with Teva Pharmaceutical Industries.
Funding history · 9 rounds · $21.8M total
2019-04
Grant
$2.5M
2016-05
Grant
$2.2M
2015-04
Grant
$1.6M
2013-11
Grant
$1.7M
2013-04
Grant
$1.5M
2012-10
Undisclosed Round
$3.5M
★ BioTime Inc.
2010-09
Undisclosed Round
$7.1M
★ BioTime Inc.★ Hadasit Bio-Holdings★ Teva Pharmaceuticals
2009-09
Convertible Debt
$1.0M
★ Hadasit Bio-Holdings
2008-12
Grant
$650K
Headcount over time
From 26 (2018-09) to 43 (2025-10) · +17 (+65%) · 45 points · source: Finder history + radar grounding
Q&A
- What is CellCure Neurosciences' primary focus?
- CellCure Neurosciences is a biotechnology company focused on developing cell therapies using human embryonic stem cells for treating retinal and neural degenerative diseases.
- What is CellCure Neurosciences' lead product in development?
- CellCure Neurosciences' lead product is OpRegen, which contains hESC-derived RPE cells designed to treat age-related macular degeneration (AMD), specifically the dry form.
- What is the current clinical trial status of OpRegen?
- CellCure Neurosciences is currently conducting a phase 1/2 clinical trial for OpRegen to treat dry AMD.
- When was CellCure Neurosciences founded?
- CellCure Neurosciences was founded in November 2005.
- How many employees does CellCure Neurosciences have?
- CellCure Neurosciences has 11-50 employees.
- What is CellCure Neurosciences' total funding raised to date?
- CellCure Neurosciences has raised a total of $21,790,000.
- Who is the parent company of CellCure Neurosciences?
- CellCure Neurosciences is a fully owned subsidiary of California-based Lineage Cell Therapeutics, formerly known as BioTime.
- When did CellCure Neurosciences receive its most recent grant?
- In May 2019, CellCure Neurosciences received a grant of $2,500,000 from the Israel Innovation Authority.
- Which investors participated in CellCure Neurosciences' October 2010 funding round?
- In October 2010, CellCure Neurosciences received funding from BioTime Inc. and Hadasit Bio-Holdings.
Team · 1
Prof. Benjamin Reubinoff
Founder · CSO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcare
Business model
B2C
Highlights
1 Patents
Tags
regenerative-medicinedegenerative-diseasesneurologycell-therapyeye-diseasesstem-cellsbiotechnologyophthalmologymedical-technologiestreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | lineagecell.com/manufacturing/ |
|---|---|
| linkedin.com/company/10231887 |
Identifiers & details
| Legal name | CELL CURE NEUROSCIENCES LTD |
|---|---|
| Founded | 2005-11 |
| Employees (exact) | 43 |
Acquisitions & public offerings
Acquired by BioTime Inc. 2010-05
Radar intelligence
Web history (Wayback)
| Domain | lineagecell.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513752394 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2005-11-20 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 6 — violation (1), annual_report (5) |
| Registered address | עין כרם 0 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-23 | עדכון הפרה |
| 2026-06-23 | דו~ח שנתי-עדכון תחום עיסוק |
| 2026-06-23 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-06-23 | דו~ח שנתי-עדכון כתובת |
| 2026-06-23 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-06-23 | דו~ח שנתי-הוספת בעל תפקיד |